MoneyWorks4Me

The revenue for the September 2025 quarter is pegged at Rs. 27620.00 millions, about 13.48% up against Rs. 24340.00 millions recorded during the year-ago period.A good growth in profit of 29.78% reported to Rs. 5970.00  millions over Rs. 4600.00 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 10450.00 millions from 9140.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 27620.00 24340.00 13.48 53780.00 48720.00 10.39 96820.00 85330.00 13.47
Other Income -270.00 -70.00 285.71 -320.00 140.00 -328.57 320.00 910.00 -64.84
PBIDT 10450.00 9140.00 14.33 20190.00 18340.00 10.09 36070.00 29810.00 21.00
Interest 370.00 540.00 -31.48 820.00 1180.00 -30.51 2130.00 3030.00 -29.70
PBDT 9950.00 8600.00 15.70 19240.00 17160.00 12.12 33700.00 26780.00 25.84
Depreciation 1890.00 1900.00 -0.53 3760.00 3790.00 -0.79 7600.00 7610.00 -0.13
PBT 8060.00 6700.00 20.30 15480.00 13370.00 15.78 26100.00 19170.00 36.15
TAX 2090.00 2100.00 -0.48 4000.00 4080.00 -1.96 7220.00 5600.00 28.93
Deferred Tax -110.00 710.00 -115.49 -180.00 1520.00 -111.84 1810.00 2380.00 -23.95
PAT 5970.00 4600.00 29.78 11480.00 9290.00 23.57 18880.00 13570.00 39.13
Equity 1692.30 1692.30 0.00 1692.30 1692.30 0.00 1692.30 1692.30 0.00
PBIDTM(%) 37.83 37.55 0.75 37.54 37.64 -0.27 37.25 34.93 6.64
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..